Trials / No Longer Available
No Longer AvailableNCT01835314
Compassionate Use of Stiripentol in Dravet Syndrome
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 1 Year – 21 Years
- Healthy volunteers
- —
Summary
Compassionate use of Stiripentol in Dravet Syndrome. This is a treatment protocol, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
Detailed description
This is a treatment protocol for compassionate use, not a research study, therefore children will only be monitored on a clinical basis for seizure improvement predominantly by parent and caregiver report.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stiripentol | Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth |
Timeline
- First posted
- 2013-04-18
- Last updated
- 2019-10-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01835314. Inclusion in this directory is not an endorsement.